EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tristel's enterprise value is GBP205.54 Mil.
Tristel's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was GBP8.86 Mil. Therefore, Tristel's EV-to-EBITDA for today is 23.19.
The historical rank and industry rank for Tristel's EV-to-EBITDA or its related term are showing as below:
LSE:TSTL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -45.33 Med: 21.51 Max: 44.89
Current: 23.19
During the past 13 years, the highest EV-to-EBITDA of Tristel was 44.89. The lowest was -45.33. And the median was 21.51.
LSE:TSTL's EV-to-EBITDA is ranked worse than 70.21% of 480
companies
in the Medical Devices & Instruments industry
Industry Median: 15.92
vs LSE:TSTL: 23.19
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-06-06), Tristel's stock price is GBP4.425.
Tristel's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was GBP0.125. Therefore, Tristel's PE Ratio for today is 35.40.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Tristel EV-to-EBITDA Historical Data
The historical data trend for Tristel's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tristel's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tristel's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tristel's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tristel's EV-to-EBITDA falls into.
Tristel EV-to-EBITDA Calculation
Tristel's EV-to-EBITDA for today is calculated as:
Tristel's current Enterprise Value is GBP205.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tristel's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was GBP8.86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tristel (LSE:TSTL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Tristel's share price for today is GBP4.425.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tristel's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was GBP0.125.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Tristel's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates majority of revenue from Hospital medical device decontamination.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:TSTL has been successfully added to your 